Gregory W. Schafer, Chief Operating Officer at ADURO BIOTECH, INC. (ADRO), sold 20,000 shares at $11.70 ($234K) on 2017-09-01, disclosed to the SEC on 2017-09-06.
Scheduled sale ($234k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADRO | SELL | 2017-11-08 | $159K | — | Filing → |
| ADRO | SELL | 2017-10-04 | $215K | — | Filing → |
| ADRO | SELL | 2017-09-14 | $53K | — | Filing → |